Trading up: A bioimaging system that is based on caged D‐luciferin/upconversion nanoparticle conjugate has been developed. The nanoparticles upconvert near‐infrared light into UV light, which triggers the photorelease of D‐luciferin (see scheme) and leads to enhanced fluorescence and bioluminescence signals in vitro and in vivo. The use of near‐infrared light enables deep penetration into tissue in vivo with minimum cellular damage.
Rare-earth-based nanomaterials have recently drawn considerable attention because of their unique energy upconversion (UC) capabilities. However, studies of Sc(3+)-based nanomaterials are still absent. Herein we report the synthesis and fine control of Na(x)ScF(3+x) nanocrystals by tuning of the ratio of oleic acid (OA, polar surfactant) to 1-octadecene (OD, nonpolar solvent). When the OA:OD ratio was increased from low (3:17) to high (3:7), the nanocrystals changed from pure monoclinic phase (Na(3)ScF(6)) to pure hexagonal phase (NaScF(4)) via a transition stage at an intermediate OA:OD ratio (3:9) where a mixture of nanocrystals in monoclinic and hexagonal phases was obtained and the coexistence of the two phases inside individual nanocrystals was also observed. More significantly, because of the small radius of Sc(3+), Na(x)ScF(3+x):Yb/Er nanocrystals show different UC emission from that of NaYF(4):Yb/Er nanocrystals, which broadens the applications of rare-earth-based nanomaterials ranging from optical communications to disease diagnosis.
We introduce gold nanorods (GNRs) decoration on NaYF4:Yb/Tm upconversion nanocrystals (UCNCs) by functionalizing the UCNCs with polyamidoamine generation 1 (PAMAM G1) dendrimer, followed by a single-step seed-mediated growth of long-range GNRs to enhance "biological window" upconversion emission. The up-conversion emission of GNR-decorated UCNCs can be enhanced beyond the level typically obtainable using shell-like structures up to 27-fold enhancement. Also, the enhancement can be tuned at different wavelength regions by varying the GNR aspect ratio. The GNR-decorated UCNC is further modified with 2-thiouracil for nonenzymatic detection of uric acid, revealing a detection limit as 1 pM.
Upconversion rare-earth nanomaterials (URENs) possess highly efficient near-infrared (NIR), e.g., 980 nm, laser absorption and unique energy upconversion capabilities. On the other hand, graphene and its derivatives, such as graphene oxide (GO), show excellent performance in optical limiting (OL); however, the wavelengths of currently used lasers for OL studies mainly focus on either 532 or 1064 nm. To design new-generation OL materials working at other optical regions, such as the NIR, a novel nanocomposites, GO-URENs, which combines the advantages of both its components, is synthesized by a one-step chemical reaction. Transmission electron microscopy, X-ray diffraction, infrared spectroscopy, and fluorescence studies prove that the α-phase URENs uniformly attach on the GO surface via covalent chemical bonding, which assures highly efficient energy transfer between URENs and GO, and also accounts for the significantly improved OL performance compared to either GO or URENs. The superior OL effect is also observed in the proof-of-concept thin-film product, suggesting immediate applications in making high-performance laser-protecting products and optoelectronic devices.
We report a novel, simple strategy to efficiently enhance the fluorescence of metal-coated up-conversion nanoparticles (UCNPs), NaYF 4 :Yb,Er/Tm. The UCNPs are functionalized with a polyamidoamine generation 1 (PAMAM G1) dendrimer, followed by a continuous growth of gold (Au) or silver (Ag) nanoshells to selectively enhance the up-converted green, violet and blue emissions (.20 fold).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.